Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 20;77(Suppl 7):S578-S580.
doi: 10.1093/cid/ciad548.

Considerations for Expanding Antimicrobial Resistance Surveillance Networks

Patrick Gallagher  1 , Alina Shaw  1 , Amit Bhandari  2 , Nimesh Poudyal  3 , Marianne Holm  3 , William R MacWright  1
Affiliations

Considerations for Expanding Antimicrobial Resistance Surveillance Networks

Patrick Gallagher et al. Clin Infect Dis. .

Abstract

Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) gained insight into the range of national antimicrobial resistance (AMR) stakeholders' long-term visions for AMR surveillance networks. As national AMR networks mature, stakeholders often contemplate adding laboratories to the network to achieve greater representativeness, boost data quantity, or meet other goals. Therefore, stakeholders should carefully select laboratories for expansion based on their goals and several practical criteria. Based on CAPTURA experience, the key criteria a national network may consider when expanding its AMR surveillance network include location, laboratory ownership, access to linked clinical and prescription databases, logistical ease, a laboratory's collaborative spirit, laboratory practices and equipment, laboratory staffing and quality assessments, laboratory methods and specimen types, data cleanliness and completeness, and the quantity of AMR data.

Keywords: AMR; Asia; CAPTURA; Expanding AMR surveillance network; surveillance network.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors received compensation from the UKAid Fleming Fund or its intermediaries for their work with CAPTURA and this supplement. A. B. worked for CAPTURA as a consultant in Nepal between October 2019 and May 2021. W. R. M. reports funding from the International Vaccine Institute, UKAID, and the Public Health Surveillance Group. A. S. and P. G. report funding from the Public Health Surveillance Group. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Criteria for expanding AMR surveillance networks. Abbreviations: AMR, antimicrobial resistance.
See this image and copyright information in PMC

References

    1. World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. Geneva, Switzerland: World Health Organization, 2021. Licence: CC BY-NC-SA 3.0 IGO.

Publication types

Substances